Latest Articles

  • You can observe a lot by watching
    Salvatore Mangione, MD
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 440-442; DOI: https://doi.org/10.3949/ccjm.86a.19056

    Learning to see is a personal, lifelong effort.

  • A right atrial mass
    Zeel Shah, MD, M. Chadi Alraies, MD, Ameer Harp, MD, Salam Khalil, MD, Amir Kaki, MD and Mahir Elder, MD
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 445-447; DOI: https://doi.org/10.3949/ccjm.86a.18131

    A woman with a history of endometrial adenocarcinoma presented with occasional shortness of breath and dizziness.

  • Ambulatory ECG monitoring in the age of smartphones
    David Sanders, MD, Leo Ungar, MD, Michael A. Eskander, MD and Arnold H. Seto, MD, MPA
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 483-493; DOI: https://doi.org/10.3949/ccjm.86a.18123

    Many devices are available; the best one to use depends on the specific clinical context.

  • Giant cell arteritis: An updated review of an old disease
    Timothy Rinden, DO, Eric Miller, MD and Rawad Nasr, MD
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 465-472; DOI: https://doi.org/10.3949/ccjm.86a.18103

    Glucocorticoids, the mainstay of treatment, should be started as soon as the disease is suspected.

  • Infertility: A practical framework
    Rebecca Flyckt, MD and Tommaso Falcone, MD, FRCSC, FACOG
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 473-482; DOI: https://doi.org/10.3949/ccjm.86a.18068

    Frequently asked questions and a practical framework for approaching the infertile couple.

  • Pediatric cholestatic liver disease: Successful transition of care
    Pediatric cholestatic liver disease: Successful transition of care
    Praveen Kumar Conjeevaram Selvakumar, MD, Vera Hupertz, MD, Naveen Mittal, MD, Kris V. Kowdley, MD and Naim Alkhouri, MD
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 454-464; DOI: https://doi.org/10.3949/ccjm.86a.18140

    Many more children with liver disease are surviving into adulthood and transitioning to adult care.

  • Do patients on biologic drugs for rheumatic disease need PCP prophylaxis?
    Joy-Ann Tabanor, MBBS and Santhanam Lakshminarayanan, MBBS
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 449-453; DOI: https://doi.org/10.3949/ccjm.86a.18084

    Consider it in those with granulomatosis with polyangiitis or pulmonary disease, or those on high-dose steroids.

  • Clinical trials: More to learn than the results
    Brian F. Mandell, MD
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 437-438; DOI: https://doi.org/10.3949/ccjm.86b.07019

    The details of the GIACTA trial challenge and reaffirm some of our clinical impressions about giant cell arteritis.

  • Type 2 diabetes: Evolving concepts and treatment
    Eden Miller, DO, Richard B. Aguilar, MD, Mary E. Herman, PhD and Stanley S. Schwartz, MD
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 494-504; DOI: https://doi.org/10.3949/ccjm.86a.17107

    Preserving beta cells is key. Recent studies provide compelling argument regarding treatments of choice.

  • Anti-Xa assays: What is their role today in antithrombotic therapy?
    Erika Hutt Centeno, MD, Michael Militello, PharmD, RPH, BCPS and Marcelo P. Gomes, MD
    Cleveland Clinic Journal of Medicine June 2019, 86 (6) 417-425; DOI: https://doi.org/10.3949/ccjm.86a.18029

    Should clinicians abandon the aPTT for monitoring heparin therapy in favor of anti-Xa assays?

Pages